Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite their drug candidates to market. Regis has the necessary technical and operational capabilities to fully support its clients' preclinical and clinical API needs. We offer a full range of services to support the development of our clients' lead molecules through commercialization, including process research and development, analytical development, impurity isolation and characterization, stability services, GMP API manufacturing, solid state chemistry, and high potent API manufacturing . With extensive organic expertise and collegiate collaborations, we also offer an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.
Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Primary business activity
Contract Service; Manufacturer/Innovator
Categories affiliated with Regis Technologies Inc.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation